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Hepatocellular adenomas (HCA) may undergo malignant transformation to hepatocellular carcinoma (HCC). Several HCA subtypes 
can be distinguished: H-HCA (characterized by 
biallelic inactivating mutation of hepatocyte nuclear 
factor 1A), I-HCA (activating mutations in different 
oncogenes of the Janus kinase [JAK]/signal trans-
ducer and activator of transcription [STAT] pathway), 
B-HCA (mutation in the catenin beta 1 [CTNNB1] 
gene encoding for β-catenin protein, which can be 
situated on exon 3, 7, or 8), B-IHCA (shares both 
JAK/STAT pathway activation and CTNNB1 muta-
tion) and sh-HCA (activation of sonic hedgehog 
signaling pathway).(1,2) In cases of multiple lesions, 
different subtypes of HCA may be observed.(1,3) B-(I)
HCA are associated with a higher risk of malignant 
transformation. It has been described that especially 
B-(I)HCA with exon 3 mutations (Bex3(I)HCA) are 
at high risk of HCC development, whereas the risk 
in those with exon 7/8 mutations (Bex7,8(I)HCA) 
appears to be low.(2,4) In this report, we present 2 
patients with HCA and unusual pathological findings 
that might impact clinical views.
Case 1
A 40-year-old female patient underwent a segmen-
tectomy because of an inhomogeneous hepatic mass. 
Macroscopic examination showed a solid 90-mm 
lesion with light and dark brown areas and some small 
(1-14 mm) whitish nodules (Fig. 1A). Microscopic 
 examination showed a hepatocellular proliferation 
without atypical features at the background (Fig. 1B,C). 
Glutamine synthetase (GS) appreciated a faint het-
erogeneous expression at the center and a reinforce-
ment at the periphery, a surrogate pattern of β-catenin 
activation. C-reactive protein (CRP) staining was 
negative (Fig. 1D). The sections corresponding to the 
whitish nodules revealed decreased and disorganized 
reticulin network and positivity for glypican-3 (Fig. 
1E), features pointing toward HCC transformation 
with good differentiation. Additional molecular anal-
ysis of the main lesion confirmed exon 7 mutation in 
CTNNB1 (Bex7HCA) and telomerase reverse-tran-
scriptase (TERT) promoter mutation in the areas 
with HCC transformation.
In a benchmark study from 2017, <4% of included 
patients with HCA had Bex7HCA, and malignant 
transformation was observed in none of the patients 
with Bex7,8HCA.(2) The present case shows that 
although the risk of malignant transformation in 
Bex7HCA is lower compared with Bex3HCA, it should 
not be neglected.
Case 2
A 32-year-old woman underwent a segmentec-
tomy because of multiple liver lesions. Macroscopic 
examination showed two well-demarcated, nonen-
capsulated lesions of 65 and 13 mm (Fig. 2A-I,B-I). 
Abbreviations: CRP, C-reactive protein; CTNNB1, catenin beta 1; GS, glutamine synthetase; HCA, hepatocellular adenoma; HCC, 
hepatocellular carcinoma.
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Both had alternating pale areas with dark red foci. 
Microscopic examination showed features of I-HCA 
with sinusoidal dilatation and inflammatory infil-
trates in the pseudoportal areas (Fig. 2A-II,B-II). 
Immunohistochemistry demonstrated a dense 
and diffuse staining for CRP (Fig. 2A-III,B-III). 
Moreover, in the small nodule, a diffuse staining was 
found for GS with a more intense staining at the 
periphery of the lesion, suggesting β-catenin activa-
tion (Fig. 2A-IV). Molecular analysis of the small 
nodule confirmed CTNNB1 mutation in exon 3. The 
large nodule was negative for CTNNB1 mutation.
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FIg. 1. Macroscopic and microscopic images, Case 1: (A) macroscopy of one of the small whitish nodules in the hemorrhagic background 
of the HCA, (B) microscopy of hematoxylin and eosin staining, (C) microscopy of reticulin staining denoting the disorganized reticulin 
with forming of broad liver plates, (D) immunohistochemistry of CRP with dense reinforcement of expression at the periphery, (E) 
immunohistochemistry of diffuse positive glypican-3 staining.
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Guidelines on benign liver tumors advise to base 
management decisions in patients with multiple HCA 
on the largest lesion.(5) The aforementioned bench-
mark article describes intertumor heterogeneity with 
at least one Bex3(I)HCA in 9 patients with multiple 
HCA.(2) Only 1 patient was described in whom the 
largest was an H-HCA and a smaller Bex3HCA; in 
the remaining patients, the largest tumor had the 
CTNNB1 mutation.
In conclusion, these cases illustrate the existent risk 
of malignant transformation in Bex7/8HCA. Pending 
defined indications for molecular analysis, we would 
propose performing mutational examination in all 
cases with inconclusive/equivocal immunohistochem-
istry, at least on biopsy material. Prospectively, this will 
lead to data collection and better understanding of the 
oncogenic β-catenin exon 7/8 and TERT mutations. 
Secondly, in the management of multiple HCA, the 
final decision should be made based on pathomolecu-
lar subclassification along with the diameter.
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FIg. 2. Macroscopic and microscopic images, Case 2: (A) macroscopic and microscopic images of the small lesion, (A-I) macroscopy, 
(A-II) microscopy of hematoxylin and eosin (H-E) staining, (A-III) immunohistochemistry of CRP with diffuse positive staining, 
(A-IV) immunohistochemistry of GS with diffuse positive staining; (B) macroscopic and microscopic images of the large lesion, (B-I) 
macroscopy, (B-II) microscopy of H-E staining, (B-III) immunohistochemistry of CRP with diffuse positive staining, and (B-IV) 
immunohistochemistry of GS with perivascular staining, no diffuse pattern.
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